We've found
6,570 Prostate Cancer
clinical trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Adenocarcinoma Clinical Trial
CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Olaparib and Durvalumab in Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Neoplasms Clinical Trial
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
Status: Enrolling,
Phase
IV
Updated: 3/22/2016
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
6,570 Prostate Cancer
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Updated: 12/31/1969
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Updated: 12/31/1969
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study of Olaparib and Durvalumab in Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 9/26/2013
Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Neoplasms Clinical Trial
Updated: 3/22/2016
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
Status: Enrolling,
Phase
IV
Updated: 3/22/2016
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials